Technology

ARBOK-TRINITY-Mosquito

ARBOK-TRINITY-Mosquito applies the Arbok-Repeel acid agent as public-health vector control against the Asian tiger mosquito (Aedes albopictus) — a top-100 invasive species now established in 16 EU countries and 369 regions, spreading dengue, chikungunya, and zika.

Overview

ARBOK-TRINITY-Mosquito applies the Arbok-Repeel acid agent as public-health vector control against the Asian tiger mosquito (Aedes albopictus) — a top-100 invasive species now established in 16 EU countries and 369 regions, spreading dengue, chikungunya, and zika. Established invasive mosquitoes cannot be eradicated; instead of poisoning, the agent drives them out: spraying breeding, resting, and day-rest sites (standing water, tires, pallets, gutters, shrub shade, basements) makes the zone uninhabitable, so females lose rest and blood-feeding sites and stop reproducing — the local population collapses. No poison: pollinator-safe, acids neutralize in soil, no resistance.

Applications

Treatment of mosquito breeding/resting sites in yards, parks, storm drains, tire stockpiles, greenhouses; priority at ports and hubs importing used tires and plants — intercepting the mosquito at the point of entry before it spreads.

Users: municipal vector-control agencies, port biosecurity, public-health bodies.

Operating Principle

The Arbok-Repeel acid mist disrupts the chitin–water interface and makes treated sites unsuitable; mosquitoes leave. Deprived of resting and blood-feeding sites, females do not produce offspring and the local population declines. Non-lethal — pollinator-safe; no selection pressure, so no resistance.

Limitations: drive-out, not eradication — requires repeated/area-wide application across the many breeding micro-sites; mosquito-specific field efficacy still being validated (preprint stage).

Key Parameters

Agent: Arbok-Repeel acid solution from phosphate waste. Action: makes breeding/resting sites unsuitable; non-lethal drive-out; pollinator-safe; soil-neutralizing; no resistance. Targets: standing water, tires, pallets, gutters, shrub shade, basements, ports/hubs. Platform production (Arbok-VC): under deep vacuum, ambient temperature, low specific energy draw, zero effluent.

Note: quantitative mosquito field-efficacy data are at preprint/validation stage.

Architecture and Components

Arbok-Repeel concentrate (Arbok-VC) → dilution/dosing → spraying of breeding/resting micro-sites (yards, drains, tire stockpiles); port/hub interception points; PPE/acid handling; site-mapping/monitoring.

Advantages

Technical: works where larvicides, traps, sterile males, and Wolbachia only contain — drive-out collapses local populations; no resistance (non-lethal). Economic: cheap; intercepts at ports before spread. Environmental: pollinator-safe, no broad-spectrum poisoning, soil-buffered. Public health: cuts dengue/chikungunya/zika transmission risk at the vector.

Integrations

Application of Arbok-Repeel; fits municipal vector-control and port-biosecurity programs; complements monitoring/trapping; published preprint supports adoption.

Deployment & Operation

Map and spray breeding/resting sites (standing water, tires, drains, basements) repeatedly through mosquito season; prioritize ports/hubs importing tires and plants. Area-wide municipal coverage to prevent re-colonization. Remaining: field-efficacy validation and operational protocols.

TRL

TRL 5 (confirmed by Michael). Validated in relevant environment at the agent level (Arbok-Repeel mechanism proven on other arthropods) with a published preprint; mosquito-specific field validation and municipal-protocol demonstration pending.

TRL scale:

  • TRL 1 — basic principles observed
  • TRL 2 — technology concept formulated
  • TRL 3 — experimental proof-of-concept
  • TRL 4 — validated in lab
  • TRL 5 — validated in relevant environment ← ARBOK-TRINITY-Mosquito
  • TRL 6 — demonstrated in relevant environment
  • TRL 7 — prototype in operational environment
  • TRL 8 — system complete and qualified
  • TRL 9 — proven in operational environment

Market Potential

Aedes mosquitoes and their diseases have cost the world ~$95 billion (up to $311 billion with complications); EU control alone is ~€1.3 per resident per year — hundreds of millions €/year across the risk zone — plus billions in Mediterranean tourism exposure. Chikungunya-2025 hit a record 81 outbreaks and 1,124 local cases; dengue-2024 saw Europe's largest-ever outbreak in Italy. With no method able to stop spread, a cheap, resistance-proof drive-out approach addresses a fast-growing market.

Typical Project Economics

Low-cost agent (negative-cost phosphate-waste feedstock) applied to breeding/resting sites; value from avoided outbreak-response and healthcare costs and protected tourism. Per-site/area cost specifics at validation stage; current control benchmarks ~€1.3/resident/year.

Risk Factors

Drive-out, not eradication — needs repeated, area-wide coverage across thousands of micro-sites; lapses allow re-colonization. Mosquito field efficacy still being validated (preprint stage). Municipal coordination and port-interception logistics. Regulatory classification of an acid agent for public-health use. Acid handling and PPE requirements for field crews.

Related Technologies

Arbok-Repeel · ARBOK-Trinity-Rice · ARBOK-Cassava · ARBOK-Bananas